|
US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な１，２，４−オキサジアゾ−ル誘導体
|
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
AU780191B2
(en)
*
|
1999-08-19 |
2005-03-03 |
Astrazeneca Ab |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
EP1582519A3
(en)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2002068417A2
(en)
*
|
2001-02-21 |
2002-09-06 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2004014902A2
(en)
*
|
2002-08-09 |
2004-02-19 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
|
EP1611123B8
(en)
*
|
2003-04-09 |
2013-11-13 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
EP1625123A4
(en)
*
|
2003-05-15 |
2007-08-29 |
Merck & Co Inc |
3- (2-AMINO-1-AZACYCLYL) -5-ARYL-1,2,4-OXADIAZOLE AS S1P RECEPTOR AGONISTS
|
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
AU2004303604B2
(en)
*
|
2003-12-24 |
2011-03-24 |
Prosidion Limited |
Heterocyclic derivatives as GPCR receptor agonists
|
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
AU2006239418A1
(en)
*
|
2005-04-26 |
2006-11-02 |
Neurosearch A/S |
Novel oxadiazole derivatives and their medical use
|
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
|
DK1907382T3
(en)
|
2005-07-26 |
2015-08-31 |
Bial Portela & Ca Sa |
Nitrocatecholderivater comt inhibitors as
|
|
EP1845097A1
(en)
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
|
NZ576060A
(en)
*
|
2006-09-07 |
2011-11-25 |
Actelion Pharmaceuticals Ltd |
Pyridin-4-yl derivatives as immunomodulating agents
|
|
RU2454413C2
(ru)
*
|
2006-09-08 |
2012-06-27 |
Актелион Фармасьютиклз Лтд |
Производные пиридин-3-ила в качестве иммуномодулирующих агентов
|
|
US8524746B2
(en)
*
|
2007-01-31 |
2013-09-03 |
Bial-Portela & Ca., S.A. |
Dosage regimen for COMT inhibitors
|
|
CN101627034B
(zh)
*
|
2007-03-16 |
2013-05-15 |
埃科特莱茵药品有限公司 |
氨基-吡啶衍生物作为s1p1/edg1受体激动剂
|
|
HRP20110449T1
(hr)
*
|
2007-08-17 |
2011-07-31 |
Actelion Pharmaceuticals Ltd. |
Derivati piridina kao modulatori receptora s1p1/edg1
|
|
BRPI0908340A2
(pt)
*
|
2008-02-28 |
2018-12-26 |
Bial Portela & Ca Sa |
composição farmacêutica para fármacos pouco solúveis
|
|
WO2009109906A1
(en)
*
|
2008-03-06 |
2009-09-11 |
Actelion Pharmaceuticals Ltd |
Pyridine compounds
|
|
CN102015695B
(zh)
*
|
2008-03-07 |
2014-08-27 |
埃科特莱茵药品有限公司 |
吡啶-2-基衍生物
|
|
AU2009226221A1
(en)
|
2008-03-17 |
2009-09-24 |
Bial - Portela & Ca., S.A. |
Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol
|
|
ES2813368T3
(es)
|
2008-05-14 |
2021-03-23 |
Scripps Research Inst |
Nuevos moduladores de receptores de fosfato de esfingosina
|
|
BRPI1008326A2
(pt)
|
2009-02-10 |
2015-08-25 |
Divergence Inc |
Composições e métodos para controlar nanatódeos
|
|
DK2413913T3
(da)
*
|
2009-04-01 |
2022-06-13 |
Bial Portela & Ca Sa |
Farmaceutiske formuleringer omfattende nitrocatecholderivater og fremgangsmåder til fremstilling deraf
|
|
CA2757411C
(en)
*
|
2009-04-01 |
2017-06-27 |
Teofilo Cardoso De Vasconcelos |
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
|
|
TWI410421B
(zh)
|
2009-07-16 |
2013-10-01 |
Actelion Pharmaceuticals Ltd |
吡啶－４－基衍生物
|
|
MA34910B1
(fr)
|
2011-01-19 |
2014-02-01 |
Actelion Pharmaceuticals Ltd |
Dérivés de 2-methoxy-pyridin-4-yl
|
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
|
PT2791134T
(pt)
|
2011-12-13 |
2019-12-18 |
BIAL PORTELA & Cª S A |
Composto químico útil como intermediário para a preparação de um inibidor de catecol-o-metiltransferase
|
|
WO2014127195A1
(en)
|
2013-02-15 |
2014-08-21 |
Monsanto Technology Llc |
3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles for controlling nematode pests
|
|
JP2018500300A
(ja)
|
2014-11-28 |
2018-01-11 |
ノヴィファーマ，エス．アー． |
パーキンソン病を遅延させるための医薬
|
|
PL3298008T3
(pl)
|
2015-05-20 |
2020-05-18 |
Idorsia Pharmaceuticals Ltd |
Krystaliczna postać związku, (S)-3-{4-[5-(2-cyklopentylo-6-metoksypirydyn-4-ylo)-[1,2,4]oksadiazol-3-ilo]-2-etylo-6-metylofenoksy}propano-1,2-diolu
|